3rd Umicore Catalysis Symposium

Successful 3rd Umicore Catalysis Symposium

We are thrilled to announce the resounding success of the 3rd Umicore Catalysis Symposium (UCS), recently held in Hanau. This landmark gathered 70 participants, including prominent academic researchers such as Professor John Hartwig and Marc Mauduit, to foster a collaborative environment for discussing the latest developments and challenges in homogeneous catalysis.
The symposium provided a unique platform for exchange, where attendees engaged heavily in productive discussions. The atmosphere was incredibly conducive to networking, allowing both participants and speakers to share insights and advancements in catalysis research.
Feedback from the attendees was overwhelmingly positive, with a significant number expressing their excitement for the next UCS, scheduled for 2025. The upcoming symposium is anticipated to return to the U.S. East Coast, continuing the tradition of fostering international collaboration.
Ralf Karch, Director of R&D and Chairman of this year's UCS highlighted the event's success by stating,

"With our 3rd Symposium, we more than realized our motto ‘Let’s create good chemistry. Together.’ This platform truly enabled a partnership-based exchange."

The 3rd UCS marked an important milestone in advancing collaboration and knowledge-sharing in the field of homogeneous catalysis. As we look forward to the future, we remain committed to driving innovation and building strong partnerships within the catalysis community.
Stay tuned for more updates and join us in our journey of creating good chemistry together. We eagerly anticipate the continued growth and success of the Umicore Catalysis Symposium in the years to come.

Achim Link, Solvias: Enabling catalysis on scale – development of an Ir-based catalyst for asymmetric hydrogenation
Dr. Nico Fleck, Merck: Streamlining catalysis screenings on a budget
Prof. John Hartwig, Berkeley: Catalytic functionalization of C-H bonds in small and large molecules with small and large catalysts
Dr. Georg Wuitschik & Vera Jost, Roche: HTE OS: An open-source HTE workflow and its use to develop new Pd-catalyzed arylations
Dr. Sébastien Lemaire, Janssen: Catalysis at J&J: from HTE to the plant
Dr. Philipp Oczipka, Umicore: Innovative and economically feasible process chemistry in homogeneous catalysis reviewed from industrial user perspective
Dr. Andre de Vries, Symeres: Transition-metal catalysis in small molecule API deliveries for early clinical trials
Dr. Marc Mauduit, ISCR: Chiral cyclic(Alkyl)(Amino)carbene ruthenium complexes: a novel opportunity in asymmetric olefin metathesis
Dr. Ted Judd, Amgen: Enabling development and execution of a tandem Iridium-Palladium catalyzed process for the manufacture of AMG 193
Dr. Katherine Wheelhouse, GSK: Adventures in pharmaceutical catalysis